Rating History for Sagent Pharmaceuticals (SGNT) by Piper Sandler
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/11/2016 | N/A | Downgrade | Neutral (Overweight) |
21.75 (22.00) |
15.50 (21.76) |
40.39% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/11/2016 | N/A | Downgrade | Neutral (Overweight) |
21.75 (22.00) |
15.50 (21.76) |
40.39% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||